Bibliographies thématiques / Ruthenium-dmso

Sommaire

Articles de revues
Thèses
Chapitres de livres

Littérature scientifique sur le sujet « Ruthenium-dmso »

Auteur : Grafiati

Publié le 1 avril 2023

Mis à jour le 31 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Ruthenium-dmso ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Ruthenium-dmso"

Saadh, Mohamed. "Anticancer and antiproliferative activity of ruthenium complex (II) bearing 3,3’-dicarboxy-2,2’-bipyridine ligand." Pharmacia 70, no. 3 (2023): 803–7. http://dx.doi.org/10.3897/pharmacia.70.e111508.

Texte intégral

Résumé :

Even though significant progress has been made in cancer treatment, there is always room for improvement. The experimental drug Ruthenium Complex II shows promise as a cancer treatment. In this article, the dichloro-3,3’-dicarboxy-2,2’-bipyridyl bis(dimethylsulphoxide)ruthenium(II) [RuCl2(3,3’-dcbpy)(DMSO)2], have been synthesized, characterized, and studied for its anticancer activity against MDA-MB-231 and MRC-5 cell lines, as well as its mechanisms of action and selectivity. According to research, [RuCl2 (3,3’-dcbpy)(DMSO)2], is highly cytotoxic to the MDA-MB-231 and minimum cytotoxic to MR

Styles APA, Harvard, Vancouver, ISO, etc.

Chandra, Manish, D. Shankar Pandey, M. Carmen Puerta та Pedro Valerga. "Ap-cymene-ruthenium(II)–DMSO complex, [(η6-C10H14)RuCl2(DMSO)]". Acta Crystallographica Section E Structure Reports Online 58, № 1 (2001): m28—m29. http://dx.doi.org/10.1107/s1600536801021237.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Saadh, Mohamed. "Anticancer and antiproliferative activity of ruthenium complex (II) bearing 3,3'-dicarboxy-2,2'-bipyridine ligand." Pharmacia 70, no. (3) (2023): 803–7. https://doi.org/10.3897/pharmacia.70.e111508.

Texte intégral

Résumé :

Even though significant progress has been made in cancer treatment, there is always room for improvement. The experimental drug Ruthenium Complex II shows promise as a cancer treatment. In this article, the dichloro-3,3'-dicarboxy-2,2'-bipyridyl bis(dimethylsulphoxide)ruthenium(II) [RuCl2(3,3'-dcbpy)(DMSO)2], have been synthesized, characterized, and studied for its anticancer activity against MDA-MB-231 and MRC-5 cell lines, as well as its mechanisms of action and selectivity. According to research, [RuCl2 (3,3'-dcbpy)(DMSO)2], is highly cytotoxic t

Styles APA, Harvard, Vancouver, ISO, etc.

Zhu, Dengsen, Cong Zhao, Xuesong Wang, Wenji Wang, Baohuai Wang, and Weihong Du. "Roles of DMSO-type ruthenium complexes in disaggregation of prion neuropeptide PrP106–126." RSC Advances 6, no. 19 (2016): 16055–65. http://dx.doi.org/10.1039/c5ra21523d.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Jaswal, Jaswinder S., Steven J. Rettig, and Brian R. James. "Ruthenium(III) complexes containing dimethylsulfoxide or dimethylsulfide ligands, and a new route to trans-dichlorotetrakis(dimethylsulfoxide)ruthenium(II)." Canadian Journal of Chemistry 68, no. 10 (1990): 1808–17. http://dx.doi.org/10.1139/v90-282.

Texte intégral

Résumé :

The new Ru(III) complex tran-[(dmso)2H]+[RuCl4(dmso)2]− (1) (dmso = S-bonded dimethylsulfoxide) has been synthesized. New synthetic routes are reported for mer-RuX3(dms)3 complexes (dms = dimethylsulfide, X = Cl (2) and Br (3)) and for trans-RuCl2(dmso)4 (4). The complexes have been studied spectroscopically while 1, 2 and 4 have also been characterized crystallographically. Crystals of 1 are monoclinic, P2/n, a = 9.280(3), b = 16.518(4), c = 14.034(3) Å, β = 100.78(2)°, Z = 4, ρc = 1.75 g cm−3. Crystals of 2 are orthorhombic, Pca21a = 10.764(2), b = 11.375(1), c = 12.243(1) Å, Z = 4, ρc = 1.7

Styles APA, Harvard, Vancouver, ISO, etc.

Messori, Luigi, Felix Kratz, and Enzo Alessio. "The Interaction of the Antitumor Complexes Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study." Metal-Based Drugs 3, no. 1 (1996): 1–9. http://dx.doi.org/10.1155/mbd.1996.1.

Texte intégral

Résumé :

The interaction of two antitumor ruthenium(III) complexes,-Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)]- with human serum apotransferrin (apoTf) was investigated through a number of spectroscopic techniques such as UV-Vis absorption, CD and H1 NMR spectroscopy. Interestingly, the hydrolysis profiles of these complexes in a physiological buffer are markedly affected by the presence, in solution, of apoTf suggesting the occurrence of a specific interaction of their respective hydrolysis products with the protein. The formation of stable adducts with apotransferrin has been demonstrat

Styles APA, Harvard, Vancouver, ISO, etc.

Kljun, Jakob, Saša Petriček, Dušan Žigon, Rosana Hudej, Damijan Miklavčič, and Iztok Turel. "Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine." Bioinorganic Chemistry and Applications 2010 (2010): 1–6. http://dx.doi.org/10.1155/2010/183097.

Texte intégral

Résumé :

Novel ruthenium(III) complexes with histamine[RuCl4(dmso-S)(histamineH)]⋅O(1a) and[RuCl4(dmso-S)(histamineH)](1b) have been prepared and characterized by X-ray structure analysis. Their crystal structures are similar and show a protonated amino group on the side chain of the ligand which is not very common for a simple heterocyclic derivative such as histamine. Biological assays to test the cytotoxicity of the compound1bcombined with electroporation were performed to determine its potential for future medical applications in cancer treatment.

Styles APA, Harvard, Vancouver, ISO, etc.

Rachford, Aaron A., Jeffrey L. Petersen, and Jeffrey J. Rack. "Efficient Energy Conversion in Photochromic Ruthenium DMSO Complexes." Inorganic Chemistry 45, no. 15 (2006): 5953–60. http://dx.doi.org/10.1021/ic0603398.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Groot, Broer de, Hilary A. Jenkins, Stephen J. Loeb, and Shannon L. Murphy. "Ruthenium(II) complexes of the thiacyclophane ligands 2,5,8-trithia[9]-o-cyclophane (TT[9]OC) and 5-oxa-2,8-dithia[9]-o-cyclophane (ODT[9]OC). Structures of RuCl2(DMSO)(TT[9]OC) and RuCl2(PPh3)(ODT[9]OC)." Canadian Journal of Chemistry 73, no. 7 (1995): 1102–10. http://dx.doi.org/10.1139/v95-136.

Texte intégral

Résumé :

Ruthenium(II) complexes of the thiacyclophane ligands 2,5,8-trithia[9]-o-cyclophane (TT[9]OC) and 5-oxa-2,8-dithia[9]-o-cyclophane (ODT[9]OC) were synthesized by ligand displacement reactions employing RuCl2(DMSO)4, RuCl2(PPh3)3, and RuHCl(PPh3)3 as starting materials. X-ray crystal structures of two of these complexes, RuCl2(DMSO)(TT[9]OC) and RuCl2(PPh3)(ODT[9]OC), demonstrate how TT[9]OC and ODT[9]OC bind to Ru(II). RuCl2(DMSO)(TT[9]OC) crystallized as the DMSO solvate in the orthorhombic space group Pbca with a = 19.590(5), b = 16.849(4), c = 13.149(4) Å, V = 4340(3) Å3, and Z = 8. The str

Styles APA, Harvard, Vancouver, ISO, etc.

Motswainyana, William M., and Peter A. Ajibade. "Anticancer Activities of Mononuclear Ruthenium(II) Coordination Complexes." Advances in Chemistry 2015 (February 19, 2015): 1–21. http://dx.doi.org/10.1155/2015/859730.

Texte intégral

Résumé :

Ruthenium compounds are highly regarded as potential drug candidates. The compounds offer the potential of reduced toxicity and can be tolerated in vivo. The various oxidation states, different mechanism of action, and the ligand substitution kinetics of ruthenium compounds give them advantages over platinum-based complexes, thereby making them suitable for use in biological applications. Several studies have focused attention on the interaction between active ruthenium complexes and their possible biological targets. In this paper, we review several ruthenium compounds which reportedly posses

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Thèses sur le sujet "Ruthenium-dmso"

Silva, Tiago Breve da. "Ligantes ancilares definindo a estrutura e reatividade de complexos de rutênio em ROMP: estudos teóricos e experimentais." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/75/75135/tde-17112016-130302/.

Texte intégral

Résumé :

A influência da isomeria cis/trans na reatividade de complexos do tipo [RuCl2(DMSO)3(L)], onde L = DMSO (2;4), n-butilamina (1;3) na polimerização via metátese por abertura de anel (ROMP) foi investigada. Os complexos 1 e 2 apresentaram isomeria fac, enquanto que os complexos 3 e 4 foram trans e mer, respectivamente. Os dados cristalográficos sugerem uma conformação fac para o novo complexo 1. Os parâmetros eletrônicos e estéreos dos ligantes, medidos pelos valores de pka e θ, respectivamente, foram usados para interpretação dos resultados. Os monômeros cíclicos usados foram norborneno

Styles APA, Harvard, Vancouver, ISO, etc.

VIDAL, ALESSIO. "THE ENDLESS POSSIBILITIES OF RUTHENIUM DMSO PRECURSORS IN MODERN COORDINATION CHEMISTRY: FROM NOVEL METALLACYCLES OF PORPHYRINS TO NEW ROUTES TO HETEROLEPTIC POLYPYRIDYL COMPOUNDS." Doctoral thesis, Università degli Studi di Trieste, 2021. http://hdl.handle.net/11368/2981623.

Texte intégral

Résumé :

La ricerca svolta durante questo dottorato di ricerca. e riportata in questa Tesi è incentrata sulla progettazione, preparazione e caratterizzazione di diversi sistemi porfirinici supramolecolari, sia metallaciclici che polimerici. Il Capitolo 1 contiene un'introduzione generale sul ruolo chiave delle porfirine come building block funzionali e strutturali per l'assemblaggio di strutture supramolecolari discrete, insieme ai principali concetti del metal-mediated assembly. Il Capitolo 2 è incentrato sullo studio della reattività dei due stereoisomeri [cis,cis,cisRuCl2(CO)2(dmso-O)(dmso-S)] e [ci

Styles APA, Harvard, Vancouver, ISO, etc.

Sens, Llorca Cristina. "New mono- and dinuclear ruthenium complexes containing the 3,5-bis(2-pyridyl)pyrazole ligand. Synthesis, characterization and applications." Doctoral thesis, Universitat de Girona, 2005. http://hdl.handle.net/10803/8034.

Texte intégral

Résumé :

Se han sintetizado dos nuevos complejos mononucleares de Ru, con formula [RuCl2(Hbpp)(dmso)2], a partir de la reacción entre [RuCl2(dmso)4] y Hbpp (3,5-bis(2-piridil)pirazola). El hecho que sólo tres de los seis posibles estereoisómeros se obtengan a partir de esta reacción, se ha racionalizado en base a factores estructurales y electrónicos. Estos complejos se han caracterizado de forma estructural, espectroscópica y electroquímica. En acetonitrilo en medio básico, el isómero trans,cis-[RuCl2(Hbpp)(dmso)2] da lugar a procesos de isomerización de enlace de un ligando dmso cuando el Ru(II) se o

Styles APA, Harvard, Vancouver, ISO, etc.

Ferrer, Vall-llosada Íngrid. "Development of new reusable materials based on Ru complexes with catalytic activity for olefin epoxidation and nitrile hydration." Doctoral thesis, Universitat de Girona, 2015. http://hdl.handle.net/10803/322785.

Texte intégral

Résumé :

In this thesis we present the synthesis and characterization of different types of ruthenium complexes containing N-donor ligands together with dmso, Cl and H2O ligands, along with their complete characterization through spectroscopic and electrochemical techniques. The complexes have been evaluated as catalysts for olefin epoxidation and nitrile hydration in homogeneous phase. On the other hand, taking into account the importance and advantages of the heterogeneous catalysis, we have carried out the immobilization of some of these complexes on silica-type supports and we have evaluated their

Styles APA, Harvard, Vancouver, ISO, etc.

Chapitres de livres sur le sujet "Ruthenium-dmso"

Gaur, Ruchi, and Lallan Mishra. "Tuning of Ruthenium – DMSO Complexes for Search of New Anticancer Agents." In Ruthenium Chemistry. Jenny Stanford Publishing, 2018. http://dx.doi.org/10.1201/9781315110585-10.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!